Siddhartha Kar - Concepedia

Author

Siddhartha Kar

University of Pittsburgh

Also Known As

S KAR, S Kar, S. Kar, SIDDHARTHA KAR, Siddhartha KAR, Siddhartha Kar, Siddhatha Kar

Publications

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh UPMC Hillman Cancer Center University of Pittsburgh Medical Center Science Applications International Corporation (United States)National Cancer Institute

About

Siddhartha Kar is an author at University of Pittsburgh specializing in medicine, liver physiology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	890
2	Health Sciences	4	4	119
3	Engineering	1	1	22
4	Natural Sciences	1	1	17
5	Public Health	1	1	83

Siddhartha Kar

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
p53 mutation in hepatocellular carcinoma after aflatoxin exposure Brigitte Bressac–de Paillerets, Alain Puisieux, Michael C. Kew, The Lancet HepatologyLiver PhysiologyP53 MutationPathologyLiver Cancer	1991	449
Growth Inhibition of Hepatoma Cells Induced by Vitamin K and Its Analogs Yuji Nishikawa, Brian I. Carr, Meifang Wang, Journal of Biological Chemistry	1995	139
Antitumor Activity of JS-K [<i>O</i><sup>2</sup>-(2,4-Dinitrophenyl) 1-[(4-Ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and Related <i>O</i><sup>2</sup>-Aryl Diazeniumdiolates in Vitro and in Vivo Paul J. Shami, Joseph E. Saavedra, Challice L. Bonifant, Journal of Medicinal Chemistry	2006	107
Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma*1 Siddhartha Kar Hepatology	1995	84
Design and development of pilus vaccines for Haemophilus influenzae diseases Charles C. Brinton, Melinda J. Carter, DAN B. DERBER, The Pediatric Infectious Disease Journal Occupational Health SciencesImmunologySam C. PhdCross-protectionJean A. Ms	1989	83
Transient and sustained ERK phosphorylation and nuclear translocation in growth control Siddhartha Kar, Meifang Wang, Brian I. Carr Journal of Cellular Physiology	2002	75
JS‐K, a novel non‐ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c‐Jun phosphorylation via multiple MAP kinase pathways Zhenggang Ren, Siddhartha Kar, Ziqiu Wang, Journal of Cellular Physiology	2003	53
Binding and Inhibition of Cdc25 Phosphatases by Vitamin K Analogues Siddhartha Kar, Iliya Lefterov, Meifang Wang, Biochemistry	2003	46
PM-20, a novel inhibitor of Cdc25A, induces extracellular signal–regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth <i>in vitro</i> and <i>in vivo</i> Siddhartha Kar, Meifang Wang, Yao Wei, Molecular Cancer Therapeutics	2006	46
Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK Siddhartha Kar, Meifang Wang, Seung Wook Ham, Biochemical Pharmacology K-vitamin DerivativeCell RegulationChemoprevention StrategyMedicineLiver Physiology	2006	37

Page 1